Identification of an amyloidogenic region on keratoepithelin via synthetic peptides

FEBS Letters

Volumn 581, Issue 2, 2007, Pages 241-247

  Yuan, Ching ^a   Berscheit, Heather L ^a   Huang, Andrew J W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Amyloid fibrils; Amyloidogenesis; Corneal dystrophies; Keratoepithelin; Synthetic peptide; Transforming growth factor beta 1

Indexed keywords

AMINO ACID; AMYLOID; CONGO RED; KERATOEPITHELIN; SCLEROPROTEIN; SYNTHETIC PEPTIDE; THIOFLAVINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; CHROMOSOME 5Q; CIRCULAR DICHROISM; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA EPITHELIUM; ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; GENE; GENE MUTATION; IN VITRO STUDY; KERATOEPITHELIN GENE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN METHYLATION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; STAINING; STRUCTURAL PROTEOMICS;

AMINO ACID SEQUENCE; AMYLOID; CIRCULAR DICHROISM; CONGO RED; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENCE; HUMANS; METHYLATION; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846218303     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.12.019     Document Type: Article

References (37)

1. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., and Purchio A.F. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 11 (1992) 511-522
2. Skonier J., Bennett K., Rothwell V., Kosowski S., Plowman G., Wallace P., Edelhoff S., Disteche C., Neubauer M., Marquardt H., Rodgers J., and Purchio A.F. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol. 13 (1994) 571-584
3. Munier F.L., Korvatska E., Djemai A., Le Paslier D., Zografos L., Pescia G., and Schorderet D.F. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet. 15 (1997) 247-251
4. Munier F.L., Frueh B.E., Othenin-Girard P., Uffer S., Cousin P., Wang M.X., Heon E., Black G.C., Blasi M.A., Balestrazzi E., Lorenz B., Escoto R., Barraquer R., Hoeltzenbein M., Gloor B., Fossarello M., Singh A.D., Arsenijevic Y., Zografos L., and Schorderet D.F. BIGH3 mutation spectrum in corneal dystrophies. Invest. Ophthalmol. Vis. Sci. 43 (2002) 949-954
5. Klintworth G.K. The molecular genetics of the corneal dystrophies - current status. Front. Biosci. 8 (2003) 687-713
6. Hirano K., Klintworth G.K., Zhan Q., Bennett K., and Cintron C. Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuch's dystrophic corneas. Curr. Eye Res. 15 (1996) 965-972
7. Billings P.C., Whitbeck J.C., Abams W.R., Cohen A.J., Engelsberg B.N., Howard P.S., and Rosenbloon J. The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interact with fibronectin. J. Biol. Chem. 277 (2002) 28003-28009
8. Kim J.E., Kim S.J., Lee B.H., Park R.W., Kim K.S., and Kim I.S. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J. Biol. Chem. 275 (2000) 30907-30915
9. Bae J.S., Lee S.H., Kim J.E., Choi J.Y., Park R.W., Park J., Park H.S., Sohn Y.S., Lee D.S., Bae L.E., and Kim I.S. Betaig-h3 supports keratinocyte adhesion, migration and proliferation through alpha3beta1 integrin. Biochem. Biophys. Res. Commun. 294 (2002) 940-948
10. Korvatska E., Henry H., Mashima Y., Yamada M., Bachmann C., Munier F.L., and Schorderet D.F. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J. Biol. Chem. 275 (2000) 11465-11469
11. Stix B., Leber M., Bingemer P., Gross C., Ruschoff J., Fandrich M., Schorderet D.F., Vorwerk C.K., Zacharias M., Roessner A., and Rocken C. Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1133-1139
12. El Kochairi I., Letovanec I., Uffer S., Munier F.L., Chaubert P., and Schorderet D.F. Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy. Mol. Vis. 12 (2006) 461-466
13. Schmitt-Bernard C.F., Chavanieu A., Herrada G., Subra G., Arnaud B., Demaille J.G., Calas B., and Argiles A. BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. Eur. J. Biochem. 269 (2002) 5149-5156
14. Clout N.J., and Hohenester E. A model of FAS1 domain 4 of the corneal protein beta(ig)-h3 gives a clearer view on corneal dystrophies. Mol. Vis. 9 (2003) 440-448
15. Suesskind D., Auw-Haedrich C., Schorderet D.F., Munier F.L., and Loeffler K.U. Keratoepithelin in secondary corneal amyloidosis. Graefes Arch. Clin. Exp. Ophthalmol. 6 (2005) 1-7
16. Schmitt-Bernard C.F., Chavanieu A., Derancourt J., Arnaud B., Demaille J.G., Calas B., and Argiles A. In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3(110-131) peptides, and its relevance for lattice corneal amyloid dystrophy type I. Biochem. Biophys. Res. Commun. 273 (2000) 649-653
17. Kim J.E., Park R.W., Choi J.Y., Bae Y.C., Kim K.S., Joo C.K., and Kim I.S. Molecular properties of wild-type and mutant betaIG-H3 proteins. Invest. Ophthalmol. Vis. Sci. 43 (2002) 656-661
18. Morand S., Buchillier V., Maurer F., Bonny C., Arsenijevic Y., Munier F.L., and Schorderet D.F. Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2973-2979
19. Naiki H., Higuchi K., Hosokawa M., and Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem. 177 (1989) 244-249
20. Sciarretta K.L., Gordon D.J., and Meredith S.C. Peptide-based inhibitors of amyloid assembly. Methods Enzymol. 413 (2006) 273-312
21. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
22. Fandrich M., Fletcher M.A., and Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 410 (2001) 165-166
23. Munishkina L.A., Fink A.L., and Uversky V.N. Conformational prerequisites for formation of amyloid fibrils from histones. J. Mol. Biol. 342 (2004) 1305-1324
24. Hughes E., Burke R.M., and Doig A.J. Inhibition of toxicity in the beta-amyloid peptide fragment beta-(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. J. Biol. Chem. 275 (2000) 25109-25115
25. Gordon D.J., Sciarretta K.L., and Meredith S.C. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry 40 (2001) 8237-8245
26. Doig A.J., Hughes E., Burke R.M., Su T.J., Heenan R.K., and Lu J. Inhibition of toxicity and protofibril formation in the amyloid-beta peptide beta(25-35) using N-methylated derivatives. Biochem. Soc. Trans. 30 (2002) 537-542
27. Cruz M., Tusell J.M., Grillo-Bosch D., Albericio F., Serratosa J., Rabanal F., and Giralt E. Inhibition of beta-amyloid toxicity by short peptides containing N-methyl amino acids. J. Pept. Res. 63 (2004) 324-328
28. Kapurniotu A., Schmauder A., and Tenidis K. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J. Mol. Biol. 315 (2002) 339-350
29. Lopez De La Paz M., Goldie K., Zurdo J., Lacroix E., Dobson C.M., Hoenger A., and Serrano L. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. USA 99 (2002) 16052-16057
30. Zerovnik E. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem. 269 (2002) 3362-3371
31. Huff M.E., Balch W.E., and Kelly J.W. Pathological and functional amyloid formation orchestrated by the secretory pathway. Curr. Opin. Struct. Biol. 13 (2003) 674-682
32. Lindgren M., Sorgjerd K., and Hammarstrom P. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys. J. 88 (2005) 4200-4212
33. Rawe I.M., Zhan Q., Burrows R., Bennett K., and Cintron C. Beta-ig. Molecular cloning and in situ hybridization in corneal tissues. Invest. Ophthalmol. Vis. Sci. 38 (1997) 893-900
34. Banning C.S., Kim W.C., Randleman J.B., Kim E.K., and Stulting R.D. Exacerbation of Avellino corneal dystrophy after LASIK in North America. Cornea 25 (2006) 482-484
35. Roher A.E., Baudry J., Chaney M.O., Kuo Y.M., Stine W.B., and Emmerling M.R. Oligomerization and fibril assemble of the amyloid-beta protein. Biochim. Biophys. Acta 1502 (2000) 31-43
36. Wanker E.E. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol. Chem. 381 (2000) 937-942
37. Nilsson M.R., and Dobson C.M. In vitro characterization of lactoferrin aggregation and amyloid formation. Biochemistry 42 (2003) 375-382